AI Platform 2.2 (AIP002) is an AI-enabled medical device from Exo Imaging, listed by FDA (510(k), K260217) with a decision date of 2026-02-24. Review panel: Radiology.
| FDA submission number | K260217 |
|---|---|
| Pathway | 510(k) |
| Company | Exo Imaging |
| Review panel (specialty) | Radiology |
| FDA decision date | 2026-02-24 |
| Decision | Substantially Equivalent |
| Product code | QIH |
| Classification | Automated Radiological Image Processing Software |
| Device class | 2 |
| Regulation number | 892.2050 |
| Review time (calendar days) | 32 |
| Applicant country | US |
Official FDA database record · FDA AI-enabled device list
All Radiology AI devices · Full device index
Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.